WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Intellectual Property

Open PDF
  • Sophisticated IP Services for Sophisticated Clients

    Wilson Sonsini provides legal advice across all IP areas, from patent and trademark portfolio management to IP litigation.

  • Substantial Technology and Life Sciences IP Expertise

    As the leading provider to technology and life sciences companies, Wilson Sonsini has helped clients develop, commercialize, and protect their innovations, regardless of sector or scale.

  • Experienced IP Litigators

    Wilson Sonsini has an experienced team of litigators that represent clients in contested matters involving IP, from PTAB and patent disputes to trademark and trade secret cases.

  • The Largest Technology Transactions Team

    Wilson Sonsini's Technology Transactions practice—the largest of its kind—helps clients complete commercial transactions driven by IP.

Wilson Sonsini's comprehensive Intellectual Property practice assists clients ranging from growth-minded start-ups to multinational companies with trademark and copyright transactional matters.

The success of most companies depends on brand strength and vitality. As such, our IP attorneys understand the importance of developing sound, sophisticated IP strategies that leverage key assets, including trademarks and copyrights. They also know the value of building and protecting strong brands through advertising and promotions, particularly in highly competitive markets. In addition, they understand the importance of complying with the many applicable consumer laws and regulations, as well as the strategic value of preventative and proactive efforts.

Overview

Wilson Sonsini's comprehensive Intellectual Property practice assists clients ranging from growth-minded start-ups to multinational companies with trademark and copyright transactional matters.

The success of most companies depends on brand strength and vitality. As such, our IP attorneys understand the importance of developing sound, sophisticated IP strategies that leverage key assets, including trademarks and copyrights. They also know the value of building and protecting strong brands through advertising and promotions, particularly in highly competitive markets. In addition, they understand the importance of complying with the many applicable consumer laws and regulations, as well as the strategic value of preventative and proactive efforts.

News Articles
Wilson Sonsini Attorneys Named to Lawdragon’s 2026 500 Leading Global IP Lawyers Guide
On June 18, 2026, Lawdragon published the 2026 edition of its 500 Leading Global IP Lawyers guide, recognizing the leading attorneys that are protecting innovation, defending brand integrity, and leveraging the assets at the heart of their clients' businesses. Wilson Sonsini partners Wendy Devine, Jordan Jaffe, David Kramer, and James Yoon have been named to the 2026 guide.
Client Highlights
Wilson Sonsini Advises SonoThera on Patent Matters Related to Oversubscribed $125 Million Series B
On June 10, 2026, SonoThera, a biotechnology company developing next-generation genetic medicines to address the root causes of disease, announced the closing of an oversubscribed $125 million Series B financing round to advance its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic and expand its pipeline of targeted, redosable genetic medicines. Wilson Sonsini Goodrich & Rosati advised SonoThera on patent matters related to the transaction.
Alerts
U.S. Supreme Court Addresses Liability for Patent Infringement by Generic Pharmaceuticals
In a unanimous opinion by Justice Ketanji Brown Jackson, the U.S. Supreme Court held that Amarin, the developer of Vascepa® (reference listed drug), failed to plausibly allege that Hikma actively induced infringement of Amarin’s method of use patents based on Hikma’s statements and materials related to its generic version of Vascepa®, reversing the decision by the U.S. Court of Appeals for the Federal Circuit (Federal Circuit). Although much of the import of this decision will not be fully understood until lower courts interpret this ruling, the Supreme Court provided guidance regarding one of the requirements for alleging a claim for induced patent infringement—one must plausibly allege that the defendant actively encouraged infringing use, not merely whether others could plausibly read statements by the defendant as instructions to infringe.
Client Highlights
Firm Advises Ona Therapeutics on IP Matters Related to $86.6 Million Series B
On June 4, 2026, Ona Therapeutics, a global biopharmaceutical company pioneering first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers, announced the closing of an oversubscribed $86.6 million Series B financing. The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life Sciences, Asabys Partners, Bpifrance, as part of the InnoBio investment strategy, CDTI through SICC Innvierte, FundPlus NV, and Ysios Capital. Wilson Sonsini Goodrich & Rosati advised Ona Therapeutics on IP matters related to the transaction.

The proceeds from the Series B will be used to advance the clinical development of Ona’s lead program, ONA-255, a first-in-class ADC initially focused on breast cancer, and to progress ONA-389, a second first-in-class ADC targeting colorectal cancer. ONA-255 is designed to address treatment-resistant tumor biology through a differentiated mechanism aimed at improving the therapeutic index compared to earlier approaches. ONA-389 will advance toward first-in-human studies, expanding Ona’s pipeline in indications with significant unmet need. Ona currently retains full worldwide commercial rights to all its assets.
Client Highlights
Wilson Sonsini Advises BVF Partners on IP Matters Related to Contraline’s $92.5 Million Series B
On June 2, 2026, Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV (Google Ventures), Lumira Ventures, Invus, and other new and existing investors. Wilson Sonsini Goodrich & Rosati advised BVF Partners on IP matters related to the transaction.
News Articles
Wilson Sonsini, Attorneys Recognized in 2026 IAM Patent 1000
On May 28, 2026, IAM 1000 recognized Wilson Sonsini in the 2026 edition of IAM Patent 1000. The firm earned three rankings, and five Wilson Sonsini attorneys received individual recommendations.
View All
Insights
News Articles
Wilson Sonsini Attorneys Named to Lawdragon’s 2026 500 Leading Global IP Lawyers Guide
On June 18, 2026, Lawdragon published the 2026 edition of its 500 Leading Global IP Lawyers guide, recognizing the leading attorneys that are protecting innovation, defending brand integrity, and leveraging the assets at the heart of their clients' businesses. Wilson Sonsini partners Wendy Devine, Jordan Jaffe, David Kramer, and James Yoon have been named to the 2026 guide.
Client Highlights
Wilson Sonsini Advises SonoThera on Patent Matters Related to Oversubscribed $125 Million Series B
On June 10, 2026, SonoThera, a biotechnology company developing next-generation genetic medicines to address the root causes of disease, announced the closing of an oversubscribed $125 million Series B financing round to advance its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic and expand its pipeline of targeted, redosable genetic medicines. Wilson Sonsini Goodrich & Rosati advised SonoThera on patent matters related to the transaction.
Alerts
U.S. Supreme Court Addresses Liability for Patent Infringement by Generic Pharmaceuticals
In a unanimous opinion by Justice Ketanji Brown Jackson, the U.S. Supreme Court held that Amarin, the developer of Vascepa® (reference listed drug), failed to plausibly allege that Hikma actively induced infringement of Amarin’s method of use patents based on Hikma’s statements and materials related to its generic version of Vascepa®, reversing the decision by the U.S. Court of Appeals for the Federal Circuit (Federal Circuit). Although much of the import of this decision will not be fully understood until lower courts interpret this ruling, the Supreme Court provided guidance regarding one of the requirements for alleging a claim for induced patent infringement—one must plausibly allege that the defendant actively encouraged infringing use, not merely whether others could plausibly read statements by the defendant as instructions to infringe.
Client Highlights
Firm Advises Ona Therapeutics on IP Matters Related to $86.6 Million Series B
On June 4, 2026, Ona Therapeutics, a global biopharmaceutical company pioneering first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers, announced the closing of an oversubscribed $86.6 million Series B financing. The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life Sciences, Asabys Partners, Bpifrance, as part of the InnoBio investment strategy, CDTI through SICC Innvierte, FundPlus NV, and Ysios Capital. Wilson Sonsini Goodrich & Rosati advised Ona Therapeutics on IP matters related to the transaction.

The proceeds from the Series B will be used to advance the clinical development of Ona’s lead program, ONA-255, a first-in-class ADC initially focused on breast cancer, and to progress ONA-389, a second first-in-class ADC targeting colorectal cancer. ONA-255 is designed to address treatment-resistant tumor biology through a differentiated mechanism aimed at improving the therapeutic index compared to earlier approaches. ONA-389 will advance toward first-in-human studies, expanding Ona’s pipeline in indications with significant unmet need. Ona currently retains full worldwide commercial rights to all its assets.
Client Highlights
Wilson Sonsini Advises BVF Partners on IP Matters Related to Contraline’s $92.5 Million Series B
On June 2, 2026, Contraline, Inc., a clinical-stage biopharmaceutical company developing novel male contraceptives, announced the closing of a $92.5 million Series B financing co-led by BVF Partners L.P. and RA Capital Management, with participation from GV (Google Ventures), Lumira Ventures, Invus, and other new and existing investors. Wilson Sonsini Goodrich & Rosati advised BVF Partners on IP matters related to the transaction.
News Articles
Wilson Sonsini, Attorneys Recognized in 2026 IAM Patent 1000
On May 28, 2026, IAM 1000 recognized Wilson Sonsini in the 2026 edition of IAM Patent 1000. The firm earned three rankings, and five Wilson Sonsini attorneys received individual recommendations.
View All
Affiliated Programs
CBSA Thought Leadership Series: Intellectual Property
Wilson Sonsini is proud to sponsor the Colorado Bioscience Thought Leadership Series, a forum dedicated to exploring the critical strategic issues facing today’s life sciences companies.
Affiliated Programs
IPBC Global 2026
Wilson Sonsini is proud to sponsor the IPBC Global 2026 on June 15-17, 2026, at the InterContinental San Diego. Partner Michael Levin will serve as the moderator for this panel, "IP: The Voice of Value" on Wednesday, June 17 at 10:10 a.m.-11:10 a.m. and will be joined by leaders from Burford Capital, Qualcomm Technology Licensing, Dolby Laboratories, BASF and Sisvel International SA.
WSGR Events
Building Patent Portfolio Value and Strategic Licensing Trends for In-House Counsel
Patent portfolios are under increasing pressure to do more than protect innovation. In today’s market, in-house legal teams are being asked to manage costs, support business growth, and think more strategically about how patent assets can create long-term value. That includes making smart decisions about portfolio development and pruning, while also understanding how licensing structures, acquisitions, and patent pools can help advance business goals and reduce risk. 
Affiliated Programs
2026 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2026 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
WSGR Events
Fall Executive Dinner
Partner Rezwan Pavri is pleased to host an exclusive, invitation-only dinner for General Counsels and CFOs. He will be joined by Jordan Jaffe, a leading IP litigator and fellow partner, who will share timely insights on emerging trends in intellectual property litigation—particularly in the realm of AI. The discussion will explore how these developments are increasingly impacting boardroom decisions at fast-growing technology companies.
Speaking Engagements
Stella Masterclass - From Idea to Asset: Mastering IP Due Diligence Across the Startup Journey
Join us for our August 2025 Stella Masterclass where the Stella Community gains access to key insights and expertise from industry professionals including corporate partners, investors, founders, service providers and more! In this session, hear from firm associate Alicia Umpierre as she presents, Idea to Asset: Mastering IP Due Diligence Across the Startup Journey.
View All
Events
Affiliated Programs
CBSA Thought Leadership Series: Intellectual Property
Wilson Sonsini is proud to sponsor the Colorado Bioscience Thought Leadership Series, a forum dedicated to exploring the critical strategic issues facing today’s life sciences companies.
Affiliated Programs
IPBC Global 2026
Wilson Sonsini is proud to sponsor the IPBC Global 2026 on June 15-17, 2026, at the InterContinental San Diego. Partner Michael Levin will serve as the moderator for this panel, "IP: The Voice of Value" on Wednesday, June 17 at 10:10 a.m.-11:10 a.m. and will be joined by leaders from Burford Capital, Qualcomm Technology Licensing, Dolby Laboratories, BASF and Sisvel International SA.
WSGR Events
Building Patent Portfolio Value and Strategic Licensing Trends for In-House Counsel
Patent portfolios are under increasing pressure to do more than protect innovation. In today’s market, in-house legal teams are being asked to manage costs, support business growth, and think more strategically about how patent assets can create long-term value. That includes making smart decisions about portfolio development and pruning, while also understanding how licensing structures, acquisitions, and patent pools can help advance business goals and reduce risk. 
Affiliated Programs
2026 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2026 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
WSGR Events
Fall Executive Dinner
Partner Rezwan Pavri is pleased to host an exclusive, invitation-only dinner for General Counsels and CFOs. He will be joined by Jordan Jaffe, a leading IP litigator and fellow partner, who will share timely insights on emerging trends in intellectual property litigation—particularly in the realm of AI. The discussion will explore how these developments are increasingly impacting boardroom decisions at fast-growing technology companies.
Speaking Engagements
Stella Masterclass - From Idea to Asset: Mastering IP Due Diligence Across the Startup Journey
Join us for our August 2025 Stella Masterclass where the Stella Community gains access to key insights and expertise from industry professionals including corporate partners, investors, founders, service providers and more! In this session, hear from firm associate Alicia Umpierre as she presents, Idea to Asset: Mastering IP Due Diligence Across the Startup Journey.
View All
Ali R. Alemozafar
Partner
San Francisco
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
  • Patents and Innovations
View Profile
Matthew A. Argenti
Partner
Palo Alto
Matt is an experienced patent litigatior with an focus on post-grant review proceedings before the PTAB.
  • Litigation
View Profile
Hin Au
Partner
Palo Alto
Hin Au is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.
  • Patents and Innovations
View Profile
Matthew Bresnahan
Partner
San Diego
Matt is primary outside IP counsel to more than 50 life sciences companies in Southern California.
  • Patents and Innovations
View Profile
Ingo Hardt
Partner
San Diego
Dr. Ingo Hardt is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he assists with the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology. He has been a registered patent agent since 2003.
  • Patents and Innovations
View Profile
Michael Hostetler
Partner
San Francisco
Based in the SOMA and San Diego offices, Mike Hostetler provides strategic IP counseling to growth enterprises in the pharmaceutical and biotechnology, and information technology industries.
  • Patents and Innovations
View Profile
Lou Lieto
Partner
Boston
Dr. Lieto focuses on patent law-related matters for clients in the life sciences industry.
  • Patents and Innovations
View Profile
Clark Y. Lin
Partner
New York

Dr. Lin practices IP law and focuses on the pharmaceutical, life sciences, and biotech fields.

  • Patents and Innovations
View Profile
Chris W. McAndrew
Partner
Boston
Chris represents life sciences clients in patent and related IP matters.
  • Patents and Innovations
View Profile
Laurie K. McNamara
Partner
San Diego
Dr. Laurie McNamara is a partner in the San Diego and San Francisco offices of Wilson Sonsini Goodrich & Rosati, where she focuses her practice on matters related to intellectual property and patent prosecution strategy for early-stage through clinical-stage therapeutics companies. She counsels clients on matters related to global patent portfolio development and strategy, non-infringement, patentability, and freedom-to-operate studies. She advises company clients in connection with major financial transactions such as collaboration agreements, venture financings, merger & acquisitions, and public offerings. In addition to company-side representation, Laurie works with top venture capital firms related to IP diligence of target companies for financings. Laurie has represented venBio, OrbiMed, Logos Capital, Venrock, Foresight Capital, Novo Holdings, Vida Ventures, Avalon BioVentures, Two Bear Capital, and Samsara BioCapital in connection with financings of target companies developing biologics therapeutic programs.
  • Patents and Innovations
View Profile
View All
People
Ali R. Alemozafar
Partner
San Francisco
Ali counsels clients on patent strategy, prosecution, and diligence for financings, M&A, and IPOs.
  • Patents and Innovations
View Profile
Matthew A. Argenti
Partner
Palo Alto
Matt is an experienced patent litigatior with an focus on post-grant review proceedings before the PTAB.
  • Litigation
View Profile
Hin Au
Partner
Palo Alto
Hin Au is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Hin provides IP strategy and counseling services to clients in a wide range of technical fields, including MedTech, digital health, biotech, medical/diagnostic devices, software, robotics, autonomous vehicle technologies, and clean energy. He has assisted many clients with building their patent portfolios and securing key strategic patents. Hin has hands-on engineering industry experience, having previously worked as an R&D engineer for six years at large U.S. semiconductor corporations. A native of Singapore, Hin is also fluent in Mandarin and Cantonese.
  • Patents and Innovations
View Profile
Matthew Bresnahan
Partner
San Diego
Matt is primary outside IP counsel to more than 50 life sciences companies in Southern California.
  • Patents and Innovations
View Profile
Ingo Hardt
Partner
San Diego
Dr. Ingo Hardt is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he assists with the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology. He has been a registered patent agent since 2003.
  • Patents and Innovations
View Profile
Michael Hostetler
Partner
San Francisco
Based in the SOMA and San Diego offices, Mike Hostetler provides strategic IP counseling to growth enterprises in the pharmaceutical and biotechnology, and information technology industries.
  • Patents and Innovations
View Profile
Lou Lieto
Partner
Boston
Dr. Lieto focuses on patent law-related matters for clients in the life sciences industry.
  • Patents and Innovations
View Profile
Clark Y. Lin
Partner
New York

Dr. Lin practices IP law and focuses on the pharmaceutical, life sciences, and biotech fields.

  • Patents and Innovations
View Profile
Chris W. McAndrew
Partner
Boston
Chris represents life sciences clients in patent and related IP matters.
  • Patents and Innovations
View Profile
Laurie K. McNamara
Partner
San Diego
Dr. Laurie McNamara is a partner in the San Diego and San Francisco offices of Wilson Sonsini Goodrich & Rosati, where she focuses her practice on matters related to intellectual property and patent prosecution strategy for early-stage through clinical-stage therapeutics companies. She counsels clients on matters related to global patent portfolio development and strategy, non-infringement, patentability, and freedom-to-operate studies. She advises company clients in connection with major financial transactions such as collaboration agreements, venture financings, merger & acquisitions, and public offerings. In addition to company-side representation, Laurie works with top venture capital firms related to IP diligence of target companies for financings. Laurie has represented venBio, OrbiMed, Logos Capital, Venrock, Foresight Capital, Novo Holdings, Vida Ventures, Avalon BioVentures, Two Bear Capital, and Samsara BioCapital in connection with financings of target companies developing biologics therapeutic programs.
  • Patents and Innovations
View Profile
View All

Wilson Sonsini's Patents and Innovations practice helps clients leverage their IP, defend against claims of others, and establish a competitive position for the future in fields such as therapeutics, personalized medicine, research tools, and clean technologies. Our team helps growing companies achieve important milestones by securing, developing, and protecting their most vital IP assets, while also advising established companies responsible for advancing groundbreaking discoveries. We identify the areas in which IP protection is most critical to achieving the company's business objectives, determine the most effective methods of protection, and identify strategies to avoid issues with third-party patents.

Our patents and innovations team—which is highly integrated with the firm's corporate, litigation, and transactional practices—is comprised of more than 180 experienced patent attorneys, patent agents, and scientific advisors, most of whom possess Ph.D. or other advanced degrees in such areas as biology, chemistry, immunology, biomedical sciences, engineering, or other scientific fields. Over 170 of our attorneys and agents have been admitted to practice before the U.S. Patent and Trademark Office. In fact, our team includes several former USPTO executives, including a former Administrative Patent Judge, a former Deputy Administrator in the Office of Policy and External Affairs, a former Deputy Commissioner for Patent Operations, and a former Deputy Commissioner for Patent Administration.

Patents and Innovations

Wilson Sonsini's Patents and Innovations practice helps clients leverage their IP, defend against claims of others, and establish a competitive position for the future in fields such as therapeutics, personalized medicine, research tools, and clean technologies. Our team helps growing companies achieve important milestones by securing, developing, and protecting their most vital IP assets, while also advising established companies responsible for advancing groundbreaking discoveries. We identify the areas in which IP protection is most critical to achieving the company's business objectives, determine the most effective methods of protection, and identify strategies to avoid issues with third-party patents.

Our patents and innovations team—which is highly integrated with the firm's corporate, litigation, and transactional practices—is comprised of more than 180 experienced patent attorneys, patent agents, and scientific advisors, most of whom possess Ph.D. or other advanced degrees in such areas as biology, chemistry, immunology, biomedical sciences, engineering, or other scientific fields. Over 170 of our attorneys and agents have been admitted to practice before the U.S. Patent and Trademark Office. In fact, our team includes several former USPTO executives, including a former Administrative Patent Judge, a former Deputy Administrator in the Office of Policy and External Affairs, a former Deputy Commissioner for Patent Operations, and a former Deputy Commissioner for Patent Administration.

The professionals in Wilson Sonsini's Patent Trial and Appeal Board (PTAB) practice are well suited to navigate the complex trial proceedings at the United States Patent and Trademark Office (USPTO). We have extensive experience before the PTAB, representing clients in numerous new trial proceedings, as well as reexaminations and patent interference trials.

Our practice includes professionals with decades of experience at the PTAB, including former PTAB personnel. As the needs of a case may require, our team also collaborates with other Wilson Sonsini professionals, including federal court patent litigators and patent prosecutors, with doctorates or other advanced technical degrees. Our core team leverages firmwide IP expertise to provide comprehensive IP solutions for clients that cover strategy, prosecution, licensing, enforcement, and defense. When there is concurrent infringement litigation, our PTAB litigation team coordinates seamlessly with our other litigators.

Post-Grant Review (PTAB)

The professionals in Wilson Sonsini's Patent Trial and Appeal Board (PTAB) practice are well suited to navigate the complex trial proceedings at the United States Patent and Trademark Office (USPTO). We have extensive experience before the PTAB, representing clients in numerous new trial proceedings, as well as reexaminations and patent interference trials.

Our practice includes professionals with decades of experience at the PTAB, including former PTAB personnel. As the needs of a case may require, our team also collaborates with other Wilson Sonsini professionals, including federal court patent litigators and patent prosecutors, with doctorates or other advanced technical degrees. Our core team leverages firmwide IP expertise to provide comprehensive IP solutions for clients that cover strategy, prosecution, licensing, enforcement, and defense. When there is concurrent infringement litigation, our PTAB litigation team coordinates seamlessly with our other litigators.

One of Wilson Sonsini's key differentiators is the firm's extensive and highly regarded Technology Transactions practice (TTG), which is dedicated solely to commercial transactions driven by IP. Our TTG team consists of approximately 50 attorneys, many of whom hold advanced degrees in engineering or science and are expert in the full range of matters related to complex and sophisticated technology transactions. Each year, our attorneys negotiate hundreds of strategic business collaborations, placing clients in optimal positions to succeed in today's complex global marketplace.

Technology Transactions

One of Wilson Sonsini's key differentiators is the firm's extensive and highly regarded Technology Transactions practice (TTG), which is dedicated solely to commercial transactions driven by IP. Our TTG team consists of approximately 50 attorneys, many of whom hold advanced degrees in engineering or science and are expert in the full range of matters related to complex and sophisticated technology transactions. Each year, our attorneys negotiate hundreds of strategic business collaborations, placing clients in optimal positions to succeed in today's complex global marketplace.

Wilson Sonsini's clients include some of the best-known brands in the world. The results of our work can be seen throughout the U.S. and around the world in ads, in digital media, on store shelves, and on factory floors. The firm's long history of partnering with industry disruptors has given us the opportunity to be involved with new, innovative companies seeking to convert game-changing ideas into products, and rare skills into unique services. That means our trademark law clients have often needed more than mere mark registration and filing assistance. They've needed strategic IP vision and a comprehensive view in the course of defining their business, and their brand. And Wilson Sonsini delivered.

Wilson Sonsini also provides comprehensive transactional and counseling advice concerning copyrights, including related registration and licensing services. As the premier law firm provider to technology companies, Wilson Sonsini's IP attorneys have represented emerging online, mobile, on-demand service, and digital printing technologies, as well as market-leading participants in the highly competitive entertainment, search, social media, software, digital media, and e-commerce sectors. Additionally, Wilson Sonsini has represented clients in the retail, healthcare, life sciences, transportation, and higher education industries, as well as other types of organizations seeking to protect and leverage copyrightable works. We also counsel U.S.-based clients on international copyright matters and non-U.S. companies on operating in the United States.

Trademark and Copyright

Wilson Sonsini's clients include some of the best-known brands in the world. The results of our work can be seen throughout the U.S. and around the world in ads, in digital media, on store shelves, and on factory floors. The firm's long history of partnering with industry disruptors has given us the opportunity to be involved with new, innovative companies seeking to convert game-changing ideas into products, and rare skills into unique services. That means our trademark law clients have often needed more than mere mark registration and filing assistance. They've needed strategic IP vision and a comprehensive view in the course of defining their business, and their brand. And Wilson Sonsini delivered.

Wilson Sonsini also provides comprehensive transactional and counseling advice concerning copyrights, including related registration and licensing services. As the premier law firm provider to technology companies, Wilson Sonsini's IP attorneys have represented emerging online, mobile, on-demand service, and digital printing technologies, as well as market-leading participants in the highly competitive entertainment, search, social media, software, digital media, and e-commerce sectors. Additionally, Wilson Sonsini has represented clients in the retail, healthcare, life sciences, transportation, and higher education industries, as well as other types of organizations seeking to protect and leverage copyrightable works. We also counsel U.S.-based clients on international copyright matters and non-U.S. companies on operating in the United States.

Related Practices
  • Patents and Innovations
  • Post-Grant Review
  • Technology Transactions
  • Trademark and Advertising
  • Patent Litigation
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
Recent Insights
News Articles
Wilson Sonsini Attorneys Named to Lawdragon’s 2026 500 Leading Global IP Lawyers Guide
On June 18, 2026, Lawdragon published the 2026 edition of its 500 Leading Global IP Lawyers guide, recognizing the leading attorneys that are protecting innovation, defending brand integrity, and leveraging the assets at the heart of their clients' businesses. Wilson Sonsini partners Wendy Devine, Jordan Jaffe, David Kramer, and James Yoon have been named to the 2026 guide.
Learn More
Client Highlights
Wilson Sonsini Advises SonoThera on Patent Matters Related to Oversubscribed $125 Million Series B
On June 10, 2026, SonoThera, a biotechnology company developing next-generation genetic medicines to address the root causes of disease, announced the closing of an oversubscribed $125 million Series B financing round to advance its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic and expand its pipeline of targeted, redosable genetic medicines. Wilson Sonsini Goodrich & Rosati advised SonoThera on patent matters related to the transaction.
Learn More
View All
Recent Events
Affiliated Programs
CBSA Thought Leadership Series: Intellectual Property
Wilson Sonsini is proud to sponsor the Colorado Bioscience Thought Leadership Series, a forum dedicated to exploring the critical strategic issues facing today’s life sciences companies.
Learn More
Affiliated Programs
IPBC Global 2026
Wilson Sonsini is proud to sponsor the IPBC Global 2026 on June 15-17, 2026, at the InterContinental San Diego. Partner Michael Levin will serve as the moderator for this panel, "IP: The Voice of Value" on Wednesday, June 17 at 10:10 a.m.-11:10 a.m. and will be joined by leaders from Burford Capital, Qualcomm Technology Licensing, Dolby Laboratories, BASF and Sisvel International SA.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.